Gut-liver axis

被引:0
|
作者
S. Zeuzem
机构
[1] Medizinische Klinik II,
[2] Zentrum der Inneren Medizin,undefined
[3] Klinikum der Johann-Wolfgang-Goethe-Universität,undefined
[4] Theodor-Stern-Kai 7,undefined
[5] 60590 Frankfurt a.M.,undefined
[6] Germany e-mail: Zeuzem@em.uni-frankfurt.de Tel.: +49-69-63015297 Fax: +49-69-63014807,undefined
关键词
Keywords Enterohepatic circulation; Bile acids; Motility; Portal system; Inflammatory bowel disease;
D O I
暂无
中图分类号
学科分类号
摘要
The gut and the liver are the key organs in nutrient absorption and metabolism. Bile acids, drugs, and toxins undergo extensive enterohepatic circulation. Bile acids play a major role in several hepatic and intestinal diseases. Endotoxins deriving from intestinal Gram-negative bacteria are important in the pathogenesis of liver and systemic diseases. Chronic liver diseases can influence gastrointestinal motility, which together with other factors may contribute to bacterial overgrowth and in patients with ascites to an increased risk of spontaneous bacterial peritonitis. Patients with end-stage liver disease frequently develop portal hypertension leading to varices, gastric vascular ectasia, and portal hypertensive gastroenteropathy. Several liver and biliary abnormalities are observed in patients with inflammatory bowel disease (primary sclerosing cholangitis, autoimmune hepatitis, cholelithiasis). The primary defect in hemochromatosis is located in the intestine, causing an inappropriate increase in iron absorption, and the liver is the site of earliest and heaviest iron deposition. Elevated transaminases are observed in many patients with celiac disease, and steatohepatitis frequently develops in patients with jejunoileal bypass and short bowel syndrome. Furthermore, the liver is the primary organ for metastasis of intestinal cancer. Many viral, bacterial, fungal, and parasitic diseases affect the intestine as well as the liver and the biliary tract.
引用
收藏
页码:59 / 82
页数:23
相关论文
共 50 条
  • [21] Gut-liver axis: barriers and functional circuits
    Pabst, Oliver
    Hornef, Mathias W.
    Schaap, Frank G.
    Cerovic, Vuk
    Clavel, Thomas
    Bruns, Tony
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (07) : 447 - 461
  • [22] The Gut-Liver Axis in Primary Sclerosing Cholangitis
    Eksteen, Bertus
    [J]. CLINICS IN LIVER DISEASE, 2016, 20 (01) : 1 - +
  • [23] Gut-liver axis in health and disease Abstracts
    不详
    [J]. CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 1 (02) : 51 - 96
  • [24] Gut-liver axis signaling in portal hypertension
    Simbrunner, Benedikt
    Mandorfer, Mattias
    Trauner, Michael
    Reiberger, Thomas
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (39) : 5897 - 5917
  • [25] Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies
    Giordano, Debora Maria
    Pinto, Claudio
    Maroni, Luca
    Benedetti, Antonio
    Marzioni, Marco
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [26] Gut-liver axis in inflammatory bowel disease
    Egresi Anna
    Kovacs Agota
    Szilvas Agnes
    Blazovics Anna
    [J]. ORVOSI HETILAP, 2017, 158 (26) : 1014 - 1021
  • [27] Lipotoxicity and the gut-liver axis in NASH pathogenesis
    Marra, Fabio
    Svegliati-Baroni, Gianluca
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 (02) : 280 - 295
  • [28] Microbiota and Gut-Liver Axis: An Unbreakable Bond?
    Sivaprasadan, Saraswathy
    Anila, K. N.
    Nair, Krishnanunni
    Mallick, Shweta
    Biswas, Lalitha
    Valsan, Arun
    Praseedom, Raaj Kumar
    Nair, Bipin Kumar G.
    Sudhindran, Surendran
    [J]. CURRENT MICROBIOLOGY, 2024, 81 (07)
  • [29] ADVANCED AGE, ETHANOL, AND THE GUT-LIVER AXIS
    McMahan, R. H.
    Mullen, J.
    Najarro, K. M.
    Hulsebus, H.
    Frank, D. N.
    Kovacs, E. J.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 : 35A - 35A
  • [30] The Effect of Lithocholic Acid on the Gut-Liver Axis
    Sheng, Wei
    Ji, Guang
    Zhang, Li
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13